Skip to content

Clinical trials

Leukemia, Lymphocytic, Chronic, B-Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Country / region: Japan Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20133
20142
20161
20194
20204
20216
20223
20237
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting13
Completed13
Recruiting11
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Loxo Oncology, Inc.5
BeOne Medicines4
Janssen Research & Development, LLC4
AstraZeneca3
Eli Lilly and Company3
Merck Sharp & Dohme LLC3
Gilead Sciences2
Novartis Pharmaceuticals2
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell40
Lymphoma, Non-Hodgkin16
Lymphoma, Follicular13
Lymphoma, Mantle-Cell9
Lymphoma, B-Cell7
Lymphoma, B-Cell, Marginal Zone7
Lymphoma, Large B-Cell, Diffuse6
Recurrence6
Waldenstrom Macroglobulinemia6
Hematologic Diseases4

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.